Pituitary microadenomas in children: a cause of growth failure

Journal of Microsurgery
|January 1, 1980
PubMed

Insights

Pituitary microadenomas in children can cause growth failure and growth hormone deficiency. Surgical removal of these tumors led to normal growth resumption in all studied patients.

Area of Science:

  • Pediatric Endocrinology
  • Neurosurgery
  • Diagnostic Imaging

Background:

  • Prepubertal idiopathic growth failure is a clinical challenge.
  • Growth hormone deficiency can manifest as significant growth impairment.
  • Pituitary microadenomas are rare causes of growth failure in children.

Purpose of the Study:

  • To investigate the role of pituitary microadenomas in prepubertal growth failure.
  • To evaluate diagnostic methods for identifying these microadenomas.
  • To assess the efficacy of surgical intervention for tumor removal and growth restoration.

Main Methods:

  • Case series of six children presenting with growth failure.
  • Laboratory evaluation for growth hormone deficiency.
  • Radiological assessment including skull X-rays, tomography, and CT scanning.
  • Surgical tumor resection via a transsphenoidal approach.

Main Results:

  • All six patients exhibited growth failure (≤2 cm/yr) and confirmed growth hormone deficiency.
  • Standard radiography and tomography did not reveal significant sella turcica abnormalities.
  • CT scanning successfully identified pituitary microadenomas as nodular areas of increased density.
  • All patients experienced resumption of normal growth post-surgery.

Conclusions:

  • Pituitary microadenomas should be considered in the differential diagnosis of prepubertal growth failure.
  • CT scanning is crucial for diagnosing microadenomas not evident on conventional imaging.
  • Transsphenoidal surgical resection is an effective treatment for restoring growth in affected children.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...